Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising cost. More rel=”nofollow” href=”https://www.mckinsey.com/featured-insights/the-next-normal/biotech”>than 200 startups are now competing to weave AI directly into research workflows, attracting growing interest from investors. rel=”nofollow” href=”https://converge-bio.com/”Converge Bio is the latest company to ride that shift, securing new capital as competition in the AI-driven drug discovery space heats up.
The Boston- and Tel Aviv–based startup, which helps pharma and biotech companies…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.fyi/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)